These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9437261)

  • 21. Seroconversion to simian immunodeficiency virus in two laboratory workers.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Sep; 41(36):678-81. PubMed ID: 1513304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonhuman primate retroviruses from Cambodia: high simian foamy virus prevalence, identification of divergent STLV-1 strains and no evidence of SIV infection.
    Ayouba A; Duval L; Liégeois F; Ngin S; Ahuka-Mundeke S; Switzer WM; Delaporte E; Ariey F; Peeters M; Nerrienet E
    Infect Genet Evol; 2013 Aug; 18():325-34. PubMed ID: 23612320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates.
    Shen X; Duffy R; Howington R; Cope A; Sadagopal S; Park H; Pal R; Kwa S; Ding S; Yang OO; Fouda GG; Le Grand R; Bolton D; Esteban M; Phogat S; Roederer M; Amara RR; Picker LJ; Seder RA; McElrath MJ; Barnett S; Permar SR; Shattock R; DeVico AL; Felber BK; Pavlakis GN; Pantaleo G; Korber BT; Montefiori DC; Tomaras GD
    J Virol; 2015 Aug; 89(16):8643-50. PubMed ID: 26018159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for simian immunodeficiency virus-specific IgM and IgG response in peripheral blood mononuclear cells of serum enzyme-linked immunosorbent assay-negative nonhuman primates.
    Jehuda-Cohen T; Powell JD; Villinger F; Mayne AE; Sell KW; Ansari AA
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):539-50. PubMed ID: 8176639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simian Immunodeficiency Virus-Infected Memory CD4
    Lee CA; Beasley E; Sundar K; Smelkinson M; Vinton C; Deleage C; Matsuda K; Wu F; Estes JD; Lafont BAP; Brenchley JM; Hirsch VM
    mBio; 2020 Apr; 11(2):. PubMed ID: 32317323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa.
    Apetrei C; Robertson DL; Marx PA
    Front Biosci; 2004 Jan; 9():225-54. PubMed ID: 14766362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simian Immunodeficiency Virus seroreactivity in inhabitants from rural Cameroon frequently in contact with non-human primates.
    Filippone C; de Oliveira F; Betsem E; Schaeffer L; Fontanet A; Lemée V; Gessain A; Plantier JC
    Virology; 2017 Mar; 503():76-82. PubMed ID: 28135660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication.
    Peng B; Voltan R; Lim L; Edghill-Smith Y; Phogat S; Dimitrov DS; Arora K; Leno M; Than S; Woodward R; Markham PD; Cranage M; Robert-Guroff M
    J Virol; 2002 Jun; 76(12):6016-26. PubMed ID: 12021334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study.
    Lee FH; Mason R; Welles H; Learn GH; Keele BF; Roederer M; Bar KJ
    J Virol; 2015 Dec; 89(24):12388-400. PubMed ID: 26423953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasensitive Immunoassay for Simian Immunodeficiency Virus p27
    Swanstrom AE; Gorelick RJ; Wu G; Howell B; Vijayagopalan A; Shoemaker R; Oswald K; Datta SA; Keele BF; Del Prete GQ; Chertova E; Bess JW; Lifson JD
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):993-1001. PubMed ID: 29869527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates.
    Switzer WM; Bhullar V; Shanmugam V; Cong ME; Parekh B; Lerche NW; Yee JL; Ely JJ; Boneva R; Chapman LE; Folks TM; Heneine W
    J Virol; 2004 Mar; 78(6):2780-9. PubMed ID: 14990698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of protection induced by attenuated simian immunodeficiency virus. IV. Protection against challenge with virus grown in autologous simian cells.
    Almond N; Corcoran T; Hull R; Walker B; Rose J; Sangster R; Silvera K; Silvera P; Cranage M; Rud E; Stott EJ
    J Med Primatol; 1997; 26(1-2):34-43. PubMed ID: 9271187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis.
    Sequar G; Britt WJ; Lakeman FD; Lockridge KM; Tarara RP; Canfield DR; Zhou SS; Gardner MB; Barry PA
    J Virol; 2002 Aug; 76(15):7661-71. PubMed ID: 12097580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of antibodies against simian immunodeficiency virus (SIV) and simian T-lymphotropic virus (STLV) in a colony of non-human primates in Kenya, East Africa.
    Otsyula M; Yee J; Jennings M; Suleman M; Gettie A; Tarara R; Isahakia M; Marx P; Lerche N
    Ann Trop Med Parasitol; 1996 Feb; 90(1):65-70. PubMed ID: 8729629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.
    Benson J; Chougnet C; Robert-Guroff M; Montefiori D; Markham P; Shearer G; Gallo RC; Cranage M; Paoletti E; Limbach K; Venzon D; Tartaglia J; Franchini G
    J Virol; 1998 May; 72(5):4170-82. PubMed ID: 9557706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection.
    Putkonen P; Thorstensson R; Albert J; Hild K; Norrby E; Biberfeld P; Biberfeld G
    AIDS; 1990 Aug; 4(8):783-9. PubMed ID: 1979745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Tat/Rev Induced Limiting Dilution Assay to Measure Viral Reservoirs in Non-Human Primate Models of HIV Infection.
    Frank I; Acharya A; Routhu NK; Aravantinou M; Harper JL; Maldonado S; Sole Cigoli M; Semova S; Mazel S; Paiardini M; Derby N; Byrareddy SN; Martinelli E
    Sci Rep; 2019 Aug; 9(1):12078. PubMed ID: 31427605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.
    Amos JD; Himes JE; Armand L; Gurley TC; Martinez DR; Colvin L; Beck K; Overman RG; Liao HX; Moody MA; Permar SR
    J Virol; 2015 Sep; 89(18):9485-98. PubMed ID: 26157116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Old world monkeys and new age science: the evolution of nonhuman primate systems virology.
    Palermo RE; Tisoncik-Go J; Korth MJ; Katze MG
    ILAR J; 2013; 54(2):166-80. PubMed ID: 24174440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression.
    Dykhuizen M; Mitchen JL; Montefiori DC; Thomson J; Acker L; Lardy H; Pauza CD
    J Gen Virol; 1998 Oct; 79 ( Pt 10)():2461-7. PubMed ID: 9780052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.